Top compounds associated with response to CCM2L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA paclitaxel UHNBreast pan-cancer AAC -0.89 0.0001
mRNA BX-912 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.12 0.0002
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.12 0.0003
mRNA vincristine CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0003
Download CSV